Counteract Media
CounterAct Completes Human Factors Engineering/Usability Engineering (HFE/UE) Formative Study with Positive Results
CounterAct’s combination rescue medication platform device completed a Human Factors Engineering/Usability Engineering (HFE/UE) formative study. The purpose of the study was to support the design and development of the CounterAct System and served to identify use...
CounterAct Nasal Device User Preference Study
With nearly 255 people dying in the United States every day from opioid overdoses, the Opioid Overdose Epidemic has showed no signs of slowing (1). In 2017, The United States Health and Human Services (HHS) developed a 5 Point Strategy to address the opioid epidemic....
Counteracting the Effects of an Opioid Overdose
This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2020, Supplement, pages 6-7. © Samedan Ltd. Respiratory depression can occur from accidental and/or intentional overdose of opioid type substances. The neurochemical process, by which...
CounterAct provides treatment for opioid overdose before it occurs
Opioid antidote can be given with prescription By BRADLEY J. FIKES AUG. 7, 2019 6 AM CounterAct, a startup founded by residents of Vista and Salt Lake City, has developed what it says is the most efficient way to get an antidote to opioid overdose patients. Called the...
130 A Day And Growing: Answering The US Opioid Overdose Epidemic
In this article, Todd Pizitz, PhD, and Donald Mealing, both Co-Founders of CounterAct, discuss the ongoing opioid crisis in the US and the current use of the opioid reversal medication naxalone, and introduce the CounterAct device for naxalone home use. In the US in...
Breakthrough Opioid Overdose Nasal Spray Device Gets Closer to Reality
FDA Accepts CounterAct Proposal to Develop A New Opioid Overdose Spray Device that Fits Patient's Standard Opioid Prescription Pill Bottles. In September, 2018 CounterAct received a positive response from the United States Food and Drug Administration (FDA), enabling...